LONDON: Hedge funds have charged their investors US$1.8 trillion in fees from 1969 to the end of December 2024, according to ...

Hedge-fund investors often gripe about high fees. A new report puts the problem in sharp relief. Just over half of the ...

Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,180,000 ...

Renaissance Technologies and Marshall Wace led quant hedge funds in 2024 with solid returns of over 20%.

Marshall Wace, which is one of the UK’s most successful hedge funds, unveiled its annual financial results in new company ...

Procyon Advisors LLC trimmed its position in Coterra Energy Inc. (NYSE:CTRA – Free Report) by 4.3% in the fourth quarter, ...

Abu Dhabi has already drawn the likes of Brevan Howard Asset Management and Marshall Wace as it established itself as a burgeoning hub for hedge funds. Now, a new group of heavyweights are looking ...

Hedge fund Marshall Wace has reported plunging profits again following a massive drop in performance fees. The investment firm, co-founded by GB News backer Sir Paul Marshall, revealed its pre-tax ...

Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 ...

Marshall Wace, which is one of the UK’s most successful hedge funds, unveiled its annual financial results in new company filings. It showed a pre-tax profit of about £192 million for the year ...